Nano-phytoconstituents: Recent advances, regulatory insights, challenges, and future horizons

Basit Öğe Kaydı
dc.contributor.authorBeygi, Mohammad
dc.contributor.authorOroojalian, Fatemeh
dc.contributor.authorKarav, Sercan
dc.contributor.authorKesharwani, Prashant
dc.contributor.authorSahebkar, Amirhossein
dc.date.accessioned2025-05-29T02:57:59Z
dc.date.available2025-05-29T02:57:59Z
dc.date.issued2025
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractPhytoconstituents possess therapeutic potency in human diseases, including antioxidant, antitumor, antiinflammatory, and anti-microbial impacts, as well as cardioprotective and neuroprotective capabilities. Nonetheless, they suffer from shortcomings like low solubility and bioavailability, fast degradation upon administration, and elevated doses required to exert therapeutic effects, culminating in potential adverse effects. As a solution to these, nanoscale drug delivery systems (DDSs) such as polymeric nanoparticles (NPs), lipid-based NPs, protein-based NPs, etc. are currently devised to realize intended goals in herbal medicine, which critically are sustained release and targeted delivery of phytomedicines to affected sites. Current DDSs are formulated to encapsulate diverse phytochemicals, including curcumin, berberine, resveratrol, quercetin, baicalin, and rosmarinic acid. The ultimate nanoassembly affords superior properties such as protracted circulation time, sustained release, site-specific delivery, synergistic effects (with antitumor agents), and measurable diseasealleviating effects. This article covers recent progress in nanophytomedicines and explores how DDSs can enrich the therapeutic properties of these phytochemicals. Further, the present article covers the regulatory aspects and ethical issues to be reflected when devising such DDSs, as well as the current standing of nanophytoconstituents in clinical trials.
dc.identifier.doi10.1016/j.jddst.2025.106908
dc.identifier.issn1773-2247
dc.identifier.issn2588-8943
dc.identifier.scopus2-s2.0-105002315226
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.jddst.2025.106908
dc.identifier.urihttps://hdl.handle.net/20.500.12428/30227
dc.identifier.volume108
dc.identifier.wosWOS:001469480200001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofJournal of Drug Delivery Science and Technology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250529
dc.subjectNano-phytoconstituents
dc.subjectDrug delivery systems
dc.subjectNanotechnology
dc.subjectHerbal medicine
dc.subjectPhytomedicines
dc.titleNano-phytoconstituents: Recent advances, regulatory insights, challenges, and future horizons
dc.typeReview

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu